Poseida Therapeutics
CA - San Diego
Biotechnology1 H-1B visas (FY2023)Focus: Genome Editing Technologies
Poseida Therapeutics is a life sciences company focused on Genome Editing Technologies.
OncologyNeurology
Open Jobs
0
Pipeline & Clinical Trials
Rimiducid may be administered as indicated
Multiple MyelomaClinical Trials (1)
NCT03741127Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Phase 1P-CD19CD20-ALLO1
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedP-BCMA-ALLO1 CAR-T cells
Multiple MyelomaClinical Trials (1)
NCT04960579P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Phase 1P-CD19CD20-ALLO1 Cells
Multiple SclerosisP-MUC1C-ALLO1 CAR-T cells
Breast CancerClinical Trials (1)
NCT05239143P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Phase 1P-PSMA-101 CAR-T cells
Prostatic Neoplasms, Castration-ResistantClinical Trials (1)
NCT04249947P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
Phase 1P-BCMA-101 CAR-T cells
Multiple MyelomaClinical Trials (1)
NCT03288493P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials
H-1B (2023): 1 approval
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub